Valuation Abbott Laboratories Deutsche Boerse AG
Stocks
ABL
US0028241000
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 82.58 EUR | +0.54% |
|
-1.86% | -22.14% |
| 07-10 | S&P 500 Posts Weekly Gain as Technology, Energy Rally | MT |
| 07-10 | Zonebourse Earnings Calendar: week of July 13 to 17, 2026 |  |
Company Valuation: Abbott Laboratories
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 241,365 | 191,427 | 191,088 | 196,184 | 217,859 | 163,609 | - | - |
| Change | - | -20.69% | -0.18% | 2.67% | 11.05% | -24.9% | - | - |
| Enterprise Value (EV) 1 | 249,166 | 198,318 | 198,871 | 202,693 | 222,266 | 175,297 | 172,465 | 168,567 |
| Change | - | -20.41% | 0.28% | 1.92% | 9.66% | -21.13% | -1.62% | -2.26% |
| P/E | 35.7x | 28.1x | 33.8x | 14.8x | 33.7x | 23.2x | 19.8x | 17.3x |
| PBR | 6.93x | 5.2x | 4.94x | 4.11x | 4.18x | 3.31x | 3.17x | 2.96x |
| PEG | - | -36.9x | -2x | 0x | -0.7x | 2.67x | 1.2x | 1.2x |
| Capitalization / Revenue | 5.6x | 4.39x | 4.76x | 4.68x | 4.91x | 3.26x | 2.99x | 2.79x |
| EV / Revenue | 5.78x | 4.54x | 4.96x | 4.83x | 5.01x | 3.49x | 3.15x | 2.88x |
| EV / EBITDA | 19.4x | 15.9x | 19.5x | 19.1x | 18.9x | 13.1x | 11.8x | 10.6x |
| EV / EBIT | 22x | 17.7x | 22.3x | 21.8x | 21.6x | 15x | 13.2x | 11.7x |
| EV / FCF | 28.8x | 25.4x | 39.3x | 31.9x | 30.1x | 20.2x | 18.3x | 16.2x |
| FCF Yield | 3.47% | 3.94% | 2.54% | 3.13% | 3.33% | 4.94% | 5.47% | 6.16% |
| Dividend per Share 2 | 1.82 | 1.92 | 2.08 | 2.24 | 2.4 | 2.547 | 2.715 | 2.866 |
| Rate of return | 1.29% | 1.75% | 1.89% | 1.98% | 1.92% | 2.71% | 2.89% | 3.05% |
| EPS 2 | 3.94 | 3.91 | 3.26 | 7.64 | 3.72 | 4.043 | 4.736 | 5.437 |
| Distribution rate | 46.2% | 49.1% | 63.8% | 29.3% | 64.5% | 63% | 57.3% | 52.7% |
| Net sales 1 | 43,075 | 43,653 | 40,109 | 41,950 | 44,328 | 50,256 | 54,748 | 58,610 |
| EBITDA 1 | 12,815 | 12,485 | 10,188 | 10,635 | 11,735 | 13,414 | 14,578 | 15,961 |
| EBIT 1 | 11,324 | 11,231 | 8,911 | 9,295 | 10,301 | 11,665 | 13,038 | 14,362 |
| Net income 1 | 7,071 | 6,933 | 5,723 | 13,402 | 6,524 | 7,018 | 8,389 | 9,226 |
| Net Debt 1 | 7,801 | 6,891 | 7,783 | 6,509 | 4,407 | 11,689 | 8,857 | 4,959 |
| Reference price 2 | 140.74 | 109.79 | 110.07 | 113.11 | 125.29 | 93.93 | 93.93 | 93.93 |
| Nbr of stocks (in thousands) | 1,714,968 | 1,743,574 | 1,736,059 | 1,734,455 | 1,738,834 | 1,741,813 | - | - |
| Announcement Date | 26/01/22 | 25/01/23 | 24/01/24 | 22/01/25 | 22/01/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 19.01x | 3.31x | 11.67x | 3.53% | 107B | |
| 16.88x | 0.19x | 11.92x | 0.78% | 59.04B | |
| 31.57x | 7.65x | 20x | 1.27% | 51.72B | |
| 37.86x | 3.01x | 10.33x | 2.53% | 41.87B | |
| 39.35x | 1.42x | 12.52x | 0.2% | 34.7B | |
| 30.62x | 5.46x | 17.4x | -.--% | 28.93B | |
| 42.01x | 7.28x | 26.26x | 0.25% | 24.99B | |
| 23.76x | 3.47x | 12.49x | 1.22% | 21.05B | |
| 46.6x | 6.27x | 20.14x | 0.47% | 20.39B | |
| Average | 31.96x | 4.23x | 15.86x | 1.14% | 43.34B | |
| Weighted average by Cap. | 28.22x | 3.79x | 14.59x | 1.66% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ABT Stock
- ABL Stock
- Valuation Abbott Laboratories
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
